Concepedia

Katrijn Boon

KB

Statistics

Publications

2

Citations

22

H-Index

2

Active since

2022

Affiliations

KU Leuven(Current)

Rega Institute for Medical Research

Katrijn Boon is an author at KU Leuven specializing in drug resistance, natural sciences, and drug discovery.

ORCID

Top concepts

Publications per year

2022–2024

2

Publications

2

Identification of novel chemotypes as CXCR2 antagonists via a scaffold hopping approach from a thiazolo[4,5-d]pyrimidine

Max Van Hoof, Katrijn Boon, Tom Van Loy et al. · European Journal of Medicinal Chemistry · 2022 · 12 citations · Full text

, , +12

Systematic assessment of chemokine ligand bias at the human chemokine receptor CXCR2 indicates G protein bias over β-arrestin recruitment and receptor internalization

Katrijn Boon, Nathan Vanalken, Martyna Szpakowska et al. · Cell Communication and Signaling · 2024 · 10 citations · Full text

Rows per page

1–2 of 2